Skip to Content
Merck

H8901

Sodium 1-heptanesulfonate

BioXtra

Synonym(s):

1-Heptanesulfonic acid sodium salt

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
C7H15O3SNa
CAS Number:
22767-50-6
Molecular Weight:
202.25
NACRES:
NA.21
PubChem Substance ID:
24895834
UNSPSC Code:
12161900
EC Number:
245-210-5
MDL number:
MFCD00007543

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Sodium 1-heptanesulfonate, BioXtra

InChI key

REFMEZARFCPESH-UHFFFAOYSA-M

InChI

1S/C7H16O3S.Na/c1-2-3-4-5-6-7-11(8,9)10;/h2-7H2,1H3,(H,8,9,10);/q;+1/p-1

SMILES string

[Na+].CCCCCCCS([O-])(=O)=O

description

anionic

product line

BioXtra

mol wt

202.25 g/mol

impurities

<0.001% Phosphorus (P)
<0.1% Insoluble matter

solubility

H2O: 0.5 M at 20 °C, clear, colorless

anion traces

chloride (Cl-): <0.05%

cation traces

Al: <0.0005%
Ca: <0.005%
Cu: <0.0005%
Fe: <0.0005%
K: <0.005%
Mg: <0.0005%
NH4+: <0.05%
Pb: <0.001%
Zn: <0.0005%

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Ion-pairing reagent for HPLC, including analyses of peptides and proteins.

Storage Class

11 - Combustible Solids

wgk

WGK 2

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SHBS7682
SHBR1516
MKCN2358
MKBX5602V
MKCH7562

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Marianna Sikorska et al.
Neurobiology of aging, 35(10), 2329-2346 (2014-04-30)
Although the support for the use of antioxidants, such as coenzyme Q(10) (CoQ(10)), to treat Parkinson's disease (PD) comes from the extensive scientific evidence, the results of conducted thus far clinical trials are inconclusive. It is assumed that the efficacy
Takeshi Oshizaka et al.
International journal of pharmaceutics, 475(1-2), 292-297 (2014-08-27)
Skin concentrations of topically administered compounds need to be considered in order to evaluate their efficacies and toxicities. This study investigated the relationship between the skin permeation and concentrations of compounds, and also predicted the skin concentrations of these compounds
Miriam Dadparvar et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 88(2), 510-517 (2014-07-06)
Severe intoxications with organophosphates require the immediate administration of atropine in combination with acetyl cholinesterase (AChE) reactivators such as HI-6. Although this therapy regimen enables the treatment of peripheral symptoms, the blood-brain barrier (BBB) restricts the access of the hydrophilic
Jie Ma et al.
Pharmacology, 93(5-6), 220-224 (2014-07-12)
It is significant for patients with traumatic brain injury (TBI) to receive prehospital emergency treatment as early as possible to reduce mortality. Therefore, a new prefilled multi-drug injector was developed to improve the treatment of TBI. Here, we studied the
Erina Kitagawa et al.
Bioscience, biotechnology, and biochemistry, 79(8), 1320-1326 (2015-03-18)
We investigated the efficacy of supplementing the diet with pteroylmonoglutamic acid (PGA), choline, or phosphatidylcholine (PC) in ameliorating the lipid accumulation in rat liver that is induced by vitamin B6 (B6) deficiency. In Experiment 1, male Wistar rats were fed
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service